Acute Coronary Syndromes (ACS)

heartwire News

  • ACC No Plaque Reduction Seen With Mimetic HDL Agent in ACS The study in patients with ACS did nothing to support the HDL hypothesis, although the bioengineered agent meant to promote reverse cholesterol transport had been promising in prior studies.
  • ACC Impella Pump Takes Positive Turn in Cardiogenic Shock Study After the Impella heart pump showed no added benefit in cardiogenic shock over less costly balloon pumps in prior studies, applying best practices appears to be paying off with the device.
  • ACC Higher Leaflet Thrombosis Risk With TAVR, DAPT Not Protective Data from two studies help clarify its true rate in transcatheter vs surgical valves, but leave open who should be screened and, if dual antiplatelets aren't protective, the type and timing of anticoagulation.
  • ACC Clinical Outcomes Trials Put iFR in Same League With FFR Less patient discomfort, shorter procedures, and potential cost savings favor iFR, but will that be enough to increase physiological-guided revascularization or simply shift those already sold on FFR?

Perspective